
### [NCIT:C3113](http://purl.obolibrary.org/obo/NCIT_C3113)
**Label:** Hyperplasia

**Subclasses:** [NCIT:C3113](http://purl.obolibrary.org/obo/NCIT_C3113) (Hyperplasia), [NCIT:C3013](http://purl.obolibrary.org/obo/NCIT_C3013) (Endometrial Hyperplasia), [NCIT:C5665](http://purl.obolibrary.org/obo/NCIT_C5665) (Atypical Adenomatous Lung Hyperplasia), [NCIT:C46101](http://purl.obolibrary.org/obo/NCIT_C46101) (Neoplastic C-Cell Hyperplasia), [NCIT:C4654](http://purl.obolibrary.org/obo/NCIT_C4654) (Atypical Endometrial Hyperplasia), [NCIT:C46100](http://purl.obolibrary.org/obo/NCIT_C46100) (C-Cell Hyperplasia), [NCIT:C8355](http://purl.obolibrary.org/obo/NCIT_C8355) (Atypical Hyperplasia), [NCIT:C82995](http://purl.obolibrary.org/obo/NCIT_C82995) (Glandular Hyperplasia), [NCIT:C8356](http://purl.obolibrary.org/obo/NCIT_C8356) (Atypical Glandular Hyperplasia), [NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia), [NCIT:C35845](http://purl.obolibrary.org/obo/NCIT_C35845) (Basal Cell Hyperplasia), 

**Class expressions from DL-Learner:**

- [NCIT:C3113](http://purl.obolibrary.org/obo/NCIT_C3113) (Hyperplasia) 95.83%
- [NCIT:C8355](http://purl.obolibrary.org/obo/NCIT_C8355) (Atypical Hyperplasia) 70.83%
- [NCIT:C82995](http://purl.obolibrary.org/obo/NCIT_C82995) (Glandular Hyperplasia) 66.67%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 52.12%
- not ([CHEBI:16336](http://purl.obolibrary.org/obo/CHEBI_16336) (hyaluronic acid)) 51.51%
- not ([CHEBI:15440](http://purl.obolibrary.org/obo/CHEBI_15440) (squalene)) 51.51%
- not ([CHEBI:10545](http://purl.obolibrary.org/obo/CHEBI_10545) (electron)) 51.51%
- Thing 51.51%
- not (CARO:0010000) 51.51%
- not ([BFO:0000020](http://purl.obolibrary.org/obo/BFO_0000020) (null)) 51.51%
- not ([BFO:0000019](http://purl.obolibrary.org/obo/BFO_0000019) (null)) 51.51%
- [NCIT:C2991](http://purl.obolibrary.org/obo/NCIT_C2991) (Disease or Disorder) 47.87%
- [NCIT:C8278](http://purl.obolibrary.org/obo/NCIT_C8278) (Cancer-Related Condition) 26.99%
- [NCIT:C3341](http://purl.obolibrary.org/obo/NCIT_C3341) (Precancerous Condition) 26.99%
- [NCIT:C27551](http://purl.obolibrary.org/obo/NCIT_C27551) (Disorder by Site) 22.25%


